Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | BMY | AMGN | GILD | VRTX |
| Company | Eidos Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 127.57 | 48.45 | 266.83 | 67.80 | 396.88 |
| High | 128.49 | 48.59 | 267.51 | 67.89 | 398.10 |
| Low | 116.83 | 48.24 | 264.46 | 67.19 | 393.53 |
| Last | 122.21 | 48.39 | 265.06 | 67.40 | 397.73 |
| Change | -6.23 | -0.12 | -0.45 | -0.35 | +0.37 |
| % Change | -4.85% | -0.25% | -0.17% | -0.52% | +0.09% |
| Volume | 335,500 | 1,248,547 | 292,203 | 709,270 | 88,914 |
| 20-Day Average Volume | 113,985 | 10,980,663 | 2,176,394 | 6,198,582 | 869,062 |
| Previous Close | 128.44 | 48.51 | 265.51 | 67.75 | 397.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 51.37 | 273.88 | 70.93 | 408.74 |
| 20-Day Raw Stochastic | 36.63% | 4.88% | 6.63% | 2.21% | 10.71% |
| 20-Day Relative Strength | 56.42% | 36.65% | 39.19% | 30.87% | 38.49% |
| Weighted Alpha | +136.62 | -29.90 | +6.03 | -23.28 | +16.86 |
| Today's Opinion | 88% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -6.14% since 04/09/24 | -1.63% since 04/09/24 | -3.61% since 04/09/24 | -1.97% since 04/09/24 |
| Low | 116.83 on 01/25/21 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.26 on 04/16/24 | 393.53 on 04/16/24 |
| High | 131.08 on 01/20/21 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | -7.47% since 03/15/24 | -1.09% since 03/15/24 | -8.52% since 03/15/24 | -2.74% since 03/15/24 |
| Low | 116.24 on 01/05/21 | 48.12 on 04/15/24 | 264.35 on 04/15/24 | 67.26 on 04/16/24 | 393.53 on 04/16/24 |
| High | 132.54 on 01/04/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | -3.14% since 01/16/24 | -12.37% since 01/16/24 | -21.60% since 01/16/24 | -9.36% since 01/16/24 |
| Low | 69.38 on 10/30/20 | 47.58 on 02/06/24 | 264.35 on 04/15/24 | 67.26 on 04/16/24 | 393.53 on 04/16/24 |
| High | 132.54 on 01/04/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | -15.29% since 10/16/23 | -7.30% since 10/16/23 | -14.88% since 10/16/23 | +6.02% since 10/16/23 |
| Low | 38.44 on 07/31/20 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.26 on 04/16/24 | 341.90 on 11/16/23 |
| High | 132.54 on 01/04/21 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 98,318,080 | 142,291,856 | 84,353,968 | 102,701,272 |
| Shares Outstanding, K | 38,873 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 26,690,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -37,840,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 130,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -30,180,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | -0.16 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 02/24/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 29.51 |